Cleared Traditional

K153073 - UroNav (Version 2.0)

K153073 is an FDA 510(k) clearance for UroNav (Version 2.0), manufactured by Invivo Corporation. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 25-day FDA review.

K153073 · Invivo Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2015
Decision
25d
Days
Class 2
Risk

K153073 is an FDA 510(k) clearance for the UroNav (Version 2.0). Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Invivo Corporation (Florida, US). The FDA issued a Cleared decision on November 16, 2015 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Invivo Corporation devices

FDA 510(k) Submission Details - K153073

510(k) Number K153073 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 22, 2015
Decision Date November 16, 2015
Days to Decision 25 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 107d · This submission: 25d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1761
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K153073.
VidiStar HeartView
K152822 · Vidistar, LLC · Nov 2015
Philips IntelliSpace Cardiovascular
K153022 · Philips Medical Systems Nethrlands BV · Nov 2015
HICAT Air
K152661 · Hicat GmbH · Nov 2015
Ziostation2
K151212 · Qi Imaging, LLC · Nov 2015
Volpara Imaging Software
K152028 · Matakina Technologies Limited · Oct 2015
Visible Patient Suite
K151988 · Visible Patient, Sas · Oct 2015